Bortezomib: The Evidence of Its Clinical Impact in Multiple Myeloma

Core Evidence - New Zealand
doi 10.2147/ce.s7452
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited